NutriBand (NTRB) secures patent for abuse deterrent technology
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts NTRB Hot Sheet
Join SI Premium – FREE
NutriBand Inc. (NASDAQ: NTRB) announced the expected issuance of a U.S. patent for its Aversa™ abuse deterrent technology. The United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for the patent application titled "Abuse and Misuse Deterrent Transdermal Systems" on February 3, 2025.
The Notice of Allowance is a significant milestone for NutriBand, indicating that the USPTO intends to grant a patent once administrative procedures are completed. The technology covered by the application includes a transdermal system designed to deter the abuse and misuse of active substances.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX Super Intelligence launches partner network program
- Market Vectors Semiconductor ETF (SMH) call put ratio 1 call to 1.7 puts as share price down 4.4%
- Texas Instruments launches Bluetooth-enabled robotic vehicle for classrooms
Create E-mail Alert Related Categories
Corporate News, InvestingRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
